arginine vasopressin has been researched along with Memory Disorders in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Guo, J; Qi, J; Wang, C; Wang, Z; Wu, M; Yang, W; Zhang, J; Zhang, X; Zhao, F; Zhou, F | 1 |
| Geng, CH; Liu, X; Ma, RQ; Wang, C; Wang, CH; Wang, H; Yang, J | 1 |
| Atsak, P; Barsegyan, A; Hornberger, WB; Jacobson, PB; Roozendaal, B; van Gaalen, MM | 1 |
| Baram, TZ; Lenjavi, MR; Rice, CJ; Sandman, CA | 1 |
| Bridges, RS; Nephew, BC | 1 |
| Cheng, L; Guo, F; Jing, W; Qi, JS; Zhang, JF | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Mishima, K; Oishi, R | 1 |
| Jiang, XG; Lu, W; Xie, YL | 1 |
| Fujiyoshi, K; Kameyama, M; Nakamura, S; Okamoto, K; Suga, H | 1 |
| Borawska, M; Car, H; Wiśniewski, K | 1 |
| Kameyama, T; Nabeshima, T; Narimatsu, H; Nishimura, K; Senzaki, K; Tanaka, T; Yamada, K | 1 |
| Raber, J | 1 |
| Hirate, K; Nishikawa, T; Ohnishi, Y; Sato, T; Tanaka, K; Teramoto, T | 1 |
| Burbach, JP; Hoekstra, K; Reijmers, LG; Spruijt, BM; van Ree, JM | 1 |
| Fujii, Y; Kamei, C; Nishiga, M; Sugimoto, Y; Taga, C | 1 |
| Abe, K; Egawa, T; Fujii, M; Fujiwara, M; Inada, K; Iwasaki, K; Matsumoto, Y; Mishima, K; Tsukikawa, H | 1 |
| Richardson, DW; Robinson, AG | 1 |
| Jennekens-Schinkel, A; Lanser, JB; Wintzen, AR | 1 |
| Levitsky, DA; Strupp, BJ | 1 |
4 review(s) available for arginine vasopressin and Memory Disorders
| Article | Year |
|---|---|
New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions.
Topics: Animals; Arginine Vasopressin; Behavior, Animal; Cognition; Drug Discovery; Memory Disorders; Mental Disorders; Mice; Mice, Knockout; Receptors, Vasopressin | 2009 |
Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.
Topics: Acquired Immunodeficiency Syndrome; Adrenocorticotropic Hormone; Amygdala; Animals; Arginine Vasopressin; Aspartic Acid; Chronic Disease; Cognition Disorders; Corticotropin-Releasing Hormone; Feedback; Glucocorticoids; Glutamic Acid; Hippocampus; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Memory Disorders; Mice; Models, Biological; Obesity; Pituitary-Adrenal System; Rats; Stress, Physiological; Synaptic Transmission | 1998 |
Desmopressin.
Topics: Anemia, Sickle Cell; Animals; Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Insipidus; Drug Synergism; Enuresis; Hemophilia A; Humans; Kidney Concentrating Ability; Learning; Memory Disorders; Structure-Activity Relationship; Urinary Incontinence; von Willebrand Diseases | 1985 |
A mnemonic role for vasopressin: the evidence for and against.
Topics: Animals; Arginine Vasopressin; Arousal; Avoidance Learning; Blood-Brain Barrier; Deamino Arginine Vasopressin; Extinction, Psychological; Haplorhini; Humans; Lypressin; Memory; Memory Disorders; Mice; Rats; Rats, Brattleboro; Vasopressins | 1985 |
2 trial(s) available for arginine vasopressin and Memory Disorders
| Article | Year |
|---|---|
Arginine vasopressin improves the memory deficits in Han Chinese patients with first-episode schizophrenia.
Topics: Administration, Intranasal; Adult; Antipsychotic Agents; Arginine Vasopressin; Asian People; Cognition; Double-Blind Method; Female; Humans; Male; Memory; Memory Disorders; Middle Aged; Placebo Effect; Schizophrenia; Time Factors; Wechsler Memory Scale | 2017 |
A clinical trial with desglycinamide arginine vasopressin for the treatment of memory disorders in man.
Topics: Adult; Aged; Amnesia; Arginine Vasopressin; Clinical Trials as Topic; Cognition; Double-Blind Method; Female; Humans; Intelligence Tests; Learning; Male; Memory; Memory Disorders; Middle Aged; Oxytocin; Random Allocation; Vasopressins | 1985 |
13 other study(ies) available for arginine vasopressin and Memory Disorders
| Article | Year |
|---|---|
AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Arginine Vasopressin; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Neuroprotective Agents; Peptide Fragments | 2020 |
The Vasopressin 1b Receptor Antagonist A-988315 Blocks Stress Effects on the Retrieval of Object-Recognition Memory.
Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Corticosterone; Disease Models, Animal; Exploratory Behavior; Humans; Male; Memory Disorders; Mental Recall; Piperazines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Receptors, Vasopressin; Recognition, Psychology; Stress, Psychological; Sulfonamides; Time Factors; Tritium | 2015 |
A novel mouse model for acute and long-lasting consequences of early life stress.
Topics: Acute Disease; Age Factors; Animals; Anxiety; Arginine Vasopressin; Chronic Disease; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Environment; Female; Hippocampus; Housing, Animal; Hypothalamus; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Nesting Behavior; Pregnancy; RNA, Messenger; Stress, Psychological | 2008 |
Arginine vasopressin V1a receptor antagonist impairs maternal memory in rats.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Behavior, Animal; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Maternal Behavior; Memory Disorders; Postpartum Period; Pregnancy; Rats; Rats, Sprague-Dawley; Reaction Time; Social Behavior | 2008 |
Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Arginine Vasopressin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; Injections, Intraventricular; Long-Term Potentiation; Male; Memory Disorders; Nootropic Agents; Peptide Fragments; Rats; Rats, Wistar; Synaptic Transmission; Time Factors | 2009 |
Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.
Topics: Animals; Arginine Vasopressin; Avoidance Learning; Drug Carriers; Drug Delivery Systems; Male; Memory; Memory Disorders; Mice; Nanostructures; Nootropic Agents; Oligopeptides; Particle Size; Peptide Fragments; Polyethylene Glycols; Pyrrolidonecarboxylic Acid; Random Allocation; Scopolamine; Serum Albumin, Bovine | 2006 |
[Regional distribution of arginine-vasopressin in post mortem human brain].
Topics: Arginine Vasopressin; Brain Chemistry; Female; Humans; Male; Memory Disorders; Middle Aged; Neuromuscular Diseases; Radioimmunoassay | 1984 |
The effect of vasopressin analogue [d(CH2)5(1),Tyr(Me)2]AVP on memory process in rats with experimental amnesia.
Topics: Animals; Arginine Vasopressin; Conditioning, Classical; Electroshock; Hypoxia, Brain; Injections, Intraventricular; Male; Memory; Memory Disorders; Rats; Rats, Wistar | 1995 |
NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by beta-amyloid protein in rats.
Topics: Amyloid beta-Peptides; Animals; Arginine Vasopressin; Behavior, Animal; Choline O-Acetyltransferase; Frontal Lobe; Hippocampus; Injections, Intraventricular; Learning Disabilities; Male; Memory Disorders; Oligopeptides; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar | 1998 |
[The ameliorating effects of a novel NC-1900 on impairments of learning/memory caused by glutamic acid].
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arginine Vasopressin; Avoidance Learning; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Kainic Acid; Learning Disabilities; Male; Memory Disorders; Mice; Mice, Inbred Strains; N-Methylaspartate; Neuromuscular Depolarizing Agents; Oligopeptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Resorcinols | 1999 |
Long-term impairment of social memory in the rat after social defeat is not restored by desglycinamide-vasopressin.
Topics: Animals; Arginine Vasopressin; Chronic Disease; Dominance-Subordination; Injections, Subcutaneous; Interpersonal Relations; Male; Memory; Memory Disorders; Rats; Rats, Wistar; Reference Values; Social Isolation; Time Factors | 2001 |
Effects of vasopressin on histamine H(1) receptor antagonist-induced spatial memory deficits in rats.
Topics: Animals; Arginine Vasopressin; Brain; Diphenhydramine; Dose-Response Relationship, Drug; Histamine H1 Antagonists; Male; Maze Learning; Memory Disorders; Pyrilamine; Rats; Rats, Wistar; Scopolamine; Vasopressins | 2001 |
Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Hemicholinium 3; Hippocampus; Hormone Antagonists; Injections, Intraventricular; Male; Maze Learning; Memory; Memory Disorders; Neurotransmitter Uptake Inhibitors; Nicardipine; Peptide Fragments; Pirenzepine; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine | 2001 |